Shingo S - Search Results

1

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Reiss TF, et al. Among authors: shingo s. Arch Intern Med. 1998 Jun 8;158(11):1213-20. doi: 10.1001/archinte.158.11.1213. Arch Intern Med. 1998. PMID: 9625400 Clinical Trial.

2

Effect of montelukast on single-dose theophylline pharmacokinetics.

Malmstrom K, Schwartz J, Reiss TF, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Shingo S, Peszek I, Larson P, Ebel D, Hunt TL, Huhn RD, Bachmann K. Malmstrom K, et al. Among authors: shingo s. Am J Ther. 1998 May;5(3):189-95. doi: 10.1097/00045391-199805000-00010. Am J Ther. 1998. PMID: 10099058 Clinical Trial.

3

Correlation of airway obstruction and patient-reported endpoints in clinical studies.

Shingo S, Zhang J, Reiss TF. Shingo S, et al. Eur Respir J. 2001 Feb;17(2):220-4. doi: 10.1183/09031936.01.17202200. Eur Respir J. 2001. PMID: 11334123 Free article.

4

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.

Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, Reiss TF. Altman LC, et al. Among authors: shingo s. J Allergy Clin Immunol. 1998 Jul;102(1):50-6. doi: 10.1016/s0091-6749(98)70054-5. J Allergy Clin Immunol. 1998. PMID: 9679847 Clinical Trial.

5

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.

Storms W, Michele TM, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, Reiss TF. Storms W, et al. Among authors: shingo s. Clin Exp Allergy. 2001 Jan;31(1):77-87. doi: 10.1046/j.1365-2222.2001.00969.x. Clin Exp Allergy. 2001. PMID: 11167954

6

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.

Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM. Barnes N, et al. Among authors: shingo s. Respir Med. 2001 May;95(5):379-86. doi: 10.1053/rmed.2001.1052. Respir Med. 2001. PMID: 11392579 Free article. Review.

7

Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.

Impens N, Reiss TF, Teahan JA, Desmet M, Rossing TH, Shingo S, Zhang J, Schandevyl W, Verbesselt R, Dupont AG. Impens N, et al. Among authors: shingo s. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1442-6. doi: 10.1164/ajrccm/147.6_Pt_1.1442. Am Rev Respir Dis. 1993. PMID: 8389106 Clinical Trial.

8

Pharmacodynamics and dose-response relationship of famotidine: a double-blind randomized placebo-controlled trial.

Laskin OL, Patterson PM, Shingo S, Lasseter KC, Shamblen EC. Laskin OL, et al. Among authors: shingo s. J Clin Pharmacol. 1993 Jul;33(7):636-9. doi: 10.1002/j.1552-4604.1993.tb04716.x. J Clin Pharmacol. 1993. PMID: 8366188 Clinical Trial.

9

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses.

Friedman BS, Bel EH, Buntinx A, Tanaka W, Han YH, Shingo S, Spector R, Sterk P. Friedman BS, et al. Among authors: shingo s. Am Rev Respir Dis. 1993 Apr;147(4):839-44. doi: 10.1164/ajrccm/147.4.839. Am Rev Respir Dis. 1993. PMID: 8385430 Clinical Trial.

10

The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.

Malmstrom K, Ang J, Fricke JR, Shingo S, Reicin A. Malmstrom K, et al. Among authors: shingo s. Curr Med Res Opin. 2005 Jan;21(1):141-9. doi: 10.1185/030079904x17983. Curr Med Res Opin. 2005. PMID: 15881486 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters